Tony is a former managing editor of BRW, Shares, Personal Investor, Asset and CFO magazines. He specialises in small listed companies, IPOs, entrepreneurship and innovation and writes a weekly blog for The Sydney Morning Herald/The Age on small companies and entrepreneurs.
Recent Commentary
Should you buy or sell our big 4 banks?
Which of the big banks stands out more than the others? And is it time to take profits on bank stocks?
3 emerging markets opportunities
Here are three emerging market ETFs to consider over the next three months.
Are Invocare & Propel worth buying?
As the COVID-19 vaccine is rolled out, funeral restrictions will continue to ease. Higher-margin funeral services will resume, helping the industry to slowly recover over the next few years. Here’s ..
Are Virtus Health & the Monash IVF Group a buy?
The resumption of treatments halted by COVID-19 boosts Virtus Health and Monash IVF Group.
3 climate-change ETFs to consider
There will inevitably be as many climate-change losers as winners, given the pattern of megatrend investing. Here’s a snapshot of 3 climate-change-related ETFs that provide exposure to this trend.
Why I like these 2 telehealth stocks
Here are two long-term beneficiaries of the exponential growth in telehealth services.